Suresh Pullela, VP, Quality Operations
Suresh Pullela joined Sardocor as Vice President, Quality Operations, in January 2022.
Suresh has over 20 years of biotechnology, pharmaceutical industry experience across multiple therapeutic modalities (across early clinical to late stage/commercial companies). He has held roles in Quality Engineering/Validation, External Quality, CMC Quality Technical Operations with the companies such as PAREXEL, Baxter BioScience (now Takeda), Genentech/Roche.
Suresh most recently served as Senior Director of Quality Assurance at Harpoon Therapeutics, which includes early to mid-stage T cell engager therapy portfolio across multiple cancer indications. In addition, Suresh served as a consultant supporting FDA remediation activities. Before Harpoon, he spent 3 years at Ultragenyx where he was responsible for Quality oversight of Biologics programs spanning clinical and commercial stages of the development lifecycle.
Suresh holds a Bachelors in Engineering from Andhra University, India, and a Master of Science in Mechanical Engineering from North Carolina State University, Raleigh, NC.
Sardocor strives to improve the quality of life in patients afflicted with incurable diseases with next-generation cell and gene therapy.
2024 All Rights Reserved | Sardocor, a division of Medera